<i>MEOX2</i> promotes glioma growth and temozolomide chemoresistance

Tengfei Li; Kaijun Sun; Wanchun Yang; Meiling Zhang; Wentao Feng; Siliang Chen; Mingrong Zuo; Qiuyun Yuan; Yanhui Liu; Mina Chen

doi:10.1016/j.jpha.2023.12.002

Volume 14 Issue 9

Sep. 2024

Turn off MathJax

Article Contents

Article Navigation > Journal of Pharmaceutical Analysis > 2024 > 14(9): 100912

Tengfei Li, Kaijun Sun, Wanchun Yang, Meiling Zhang, Wentao Feng, Siliang Chen, Mingrong Zuo, Qiuyun Yuan, Yanhui Liu, Mina Chen. MEOX2 promotes glioma growth and temozolomide chemoresistance[J]. Journal of Pharmaceutical Analysis, 2024, 14(9): 100912. doi: 10.1016/j.jpha.2023.12.002

Citation:

Tengfei Li, Kaijun Sun, Wanchun Yang, Meiling Zhang, Wentao Feng, Siliang Chen, Mingrong Zuo, Qiuyun Yuan, Yanhui Liu, Mina Chen. MEOX2 promotes glioma growth and temozolomide chemoresistance[J]. Journal of Pharmaceutical Analysis, 2024, 14(9): 100912. doi: 10.1016/j.jpha.2023.12.002

Citation:

PDF( 700 KB)

MEOX2 promotes glioma growth and temozolomide chemoresistance

doi: 10.1016/j.jpha.2023.12.002

a Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, 610041, China;
b Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, 610041, China;
c Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China

Funds:

This work was supported by the grants from the Science and Technology Project, Technology Innovation Research and Development Project of Chengdu, China (Grant No.: 2022-YF05-01456-SN), Post-Doctor Research Project, West China Hospital, Sichuan University, China (Grant No.: 2021HXBH010), and the Natural Science Foundation of Sichuan Province of China (Grant No.: 2022NSFSC1428).

Received Date: Aug. 22, 2023
Accepted Date: Dec. 04, 2023
Rev Recd Date: Nov. 21, 2023
Publish Date: Dec. 10, 2023

Abstract

FullText(HTML)

References(5)

References

[1]	C. Rouse, H. Gittleman, Q.T. Ostrom, et al., Years of potential life lost for brain and CNS tumors relative to other cancers in adults in the United States, 2010, Neuro. Oncol. 18 (2016) 70-77.
[2]	D.N. Louis, A. Perry, P. Wesseling, et al., The 2021 WHO Classification of Tumors of the Central Nervous System: a summary, Neuro. Oncol. 23 (2021) 1231-1251.
[3]	T. Li, W. Yang, M. Li, et al., Engrailed 2 (EN2) acts as a glioma suppressor by inhibiting tumor proliferation/invasion and enhancing sensitivity to temozolomide, Cancer Cell Int. 20 (2020), 65.
[4]	J. Wang, Y. Chen, Q. Wang, et al., MEOX2-mediated regulation of Cathepsin S promotes cell proliferation and motility in glioma, Cell Death Dis. 13 (2022), 360.
[5]	A. Schonrock, E. Heinzelmann, B. Steffl, et al., MEOX2 homeobox gene promotes growth of malignant gliomas, Neuro. Oncol. 24 (2022) 1911-1924.